FDA-Authorized AI/ML Sepsis Prediction Tool Development
The approval path documented here is the practical playbook many health-AI teams lack: it shows what evidence regulators actually demanded, not just how the model was built. Clinical AI developers and hospital informatics leads in Singapore, Malaysia and Thailand pursuing regulatory clearance can map their own validation and drift-monitoring plans against it. It also complements regional discussions on adopting FDA-cleared decision-support tools rather than building equivalents from scratch.
NEJM AISource